Tissue morphogenesis and regeneration requires dynamic, robust control of cell proliferation, differentiation, and migration. To coordinate these complex cell behaviors, developmental signaling pathways are actuated with spatiotemporal precision, and their dysregulation can lead to congenital birth defects or tumorigenesis later on in life. While developmental biologists have largely relied on genetic tools to deconstruct these processes, our laboratory has taken a different approach. Over the past five years, we have explored how chemical technologies and high-throughput biology can deepen our understanding of developmental signaling and tissue patterning. Over the past five years, we have invented caged morpholino oligonucleotides that can be activated by light or enzymatically triggered, and we have used these chemical tools to gain new insights into notochord, somite, and medial floor plate development. We established methods for the ultrasensitive imaging of lanthanide-based probes, allowing their unique photophysical properties to be fully exploited for autofluorescence-free in vivo imaging. We have also discovered novel regulators of the Hedgehog pathway, including ARHGAP36, a non-canonical GLI transcription factor activator and oncogene, and the first specific small-molecule inhibitors of cytoplasmic dyneins. We now seek to build upon these accomplishments and push the boundaries of in vivo chemical biology, focusing on the photochemistry of metal ions, synthetic compounds, and proteins. We envision that developmental biology would benefit from new optically controlled technologies that match the cellular resolution and rapid kinetics of patterning mechanisms, including both graded and switch-like responses. Imaging modalities that enable the detection of RNAs, proteins, and their activities at physiological concentrations would be equally transformative. Our research plans for the next five years include the synthesis of photoactivatable morpholinos with greater dynamic and spectral range, directed evolution of optogenetic regulators for key developmental signaling pathways, and design of lanthanide-based tools for imaging biological molecules in whole organisms. We will apply these technologies in zebrafish models, taking advantage of their optical transparency and amenability to chemical and genetic manipulations. Our long-term goal is to use these new experimental capabilities to perturb and observe in vivo biology in unprecedented ways, changing how we study and understand the molecular mechanisms that give rise to multicellular form.

Public Health Relevance

Our research program develops chemical technologies to study tissue formation and regeneration. Our current studies explore how the photochemistry of metal ions, synthetic compounds, and proteins can be used to perturb, observe, and ultimately understand the molecular mechanisms that underlie these processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Unknown (R35)
Project #
5R35GM127030-02
Application #
9657803
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Fabian, Miles
Project Start
2018-04-01
Project End
2023-03-31
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
2
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Stanford University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305